HCA Healthcare Files 2025 Proxy Statement

Ticker: HCA · Form: DEF 14A · Filed: Mar 14, 2025 · CIK: 860730

Sentiment: neutral

Topics: proxy-statement, executive-compensation, corporate-governance

TL;DR

HCA proxy out: exec comp details, board info, shareholder proposals up for vote.

AI Summary

HCA Healthcare, Inc. filed its DEF 14A on March 14, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on the company's board of directors, compensation committee, and various equity awards granted to its named executive officers. Specific details on stock options, restricted stock units, and other incentive plans are provided, alongside financial data related to these awards.

Why It Matters

This filing provides shareholders with crucial information regarding executive pay and corporate governance, enabling informed voting decisions on proposals presented at the annual meeting.

Risk Assessment

Risk Level: medium — DEF 14A filings can reveal information about executive compensation, board composition, and shareholder proposals that may impact stock price and investor sentiment.

Key Players & Entities

FAQ

What is the period of report for this DEF 14A filing?

The conformed period of report is April 24, 2025.

When was this DEF 14A filing submitted?

The filing was submitted on March 14, 2025.

What is the Central Index Key (CIK) for HCA Healthcare, Inc.?

The CIK for HCA Healthcare, Inc. is 0000860730.

What is the fiscal year end for HCA Healthcare, Inc.?

The fiscal year end for HCA Healthcare, Inc. is December 31.

What was the former name of HCA Healthcare, Inc. prior to 2010?

The former name was HCA Holdings, Inc., with a date of name change to HCA Healthcare, Inc. on November 26, 2010.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 14, 2025 by Samuel N. Hazen regarding HCA Healthcare, Inc. (HCA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing